Biolog-id
Identification technology to manage and trace sensitive health products.
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 59 % | 13 % | 55 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Biolog-id was founded with a vision to transform the way healthcare logistics are managed. The company was established by a team of innovators who recognized the inefficiencies in the management of sensitive healthcare products like blood, plasma, and other biologics. Although specific names of the founders are not readily available, their mission was clear: to enhance safety, efficiency, and traceability in healthcare logistics.
Biolog-id developed a proprietary RFID-based solution that allows for real-time tracking and management of these critical products. This technology ensures that healthcare providers can maintain the integrity and safety of their supplies, ultimately improving patient outcomes.
A significant milestone in Biolog-id's journey was securing major funding to expand its operations and technology. This financial boost enabled the company to scale its solutions globally, partnering with healthcare institutions across various continents.
Biolog-id's impact on the healthcare industry is profound, providing a level of transparency and efficiency previously unattainable. Their solutions not only reduce waste and cost but also enhance the overall safety of healthcare logistics. Today, Biolog-id continues to innovate, driven by a commitment to improving healthcare systems worldwide.